+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Companion Animal Health Market - Global Forecast 2026-2032- Product Image
Companion Animal Health Market - Global Forecast 2026-2032- Product Image
Sale

Companion Animal Health Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337543
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Companion Animal Health Market is projected to reach USD 26.46 Billion in 2026. It is expected to continue growing at a CAGR of 8.59%, reaching USD 43.44 Billion by 2032.

The companion animal health market is expanding as pet owners increasingly treat dogs, cats, and other companion animals as members of the family. Demand is concentrated across veterinary pharmaceuticals, vaccines, parasiticides, diagnostics, nutrition, pain management, dermatology, dental care, surgical products, and digital veterinary services.

Verified industry indicators support the sector’s resilience. The American Pet Products Association reported U.S. pet industry expenditures of about USD 147 billion in 2023, with veterinary care and product spending remaining a major category. In Europe, FEDIAF data continue to show pet ownership across millions of households, reinforcing demand for preventive care, chronic disease management, and evidence-based companion animal health solutions.

Transformative Shifts in the Companion Animal Health Landscape

The companion animal health landscape is shifting from episodic treatment toward preventive, continuous, and data-enabled veterinary care. Pet owners are seeking earlier diagnostics, wellness plans, parasite prevention, nutrition guidance, and therapies that improve quality of life for aging animals. Veterinary clinics are also adopting point-of-care diagnostics, practice-management platforms, and integrated pharmacy services to improve clinical efficiency.

Innovation is accelerating in monoclonal antibodies, long-acting parasiticides, dermatology, osteoarthritis pain management, vaccines, and specialty diagnostics. At the same time, veterinary workforce shortages, cost sensitivity, and regulatory scrutiny from agencies such as the U.S. FDA Center for Veterinary Medicine and the European Medicines Agency are reshaping product development, access, and commercialization strategies.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical capability across companion animal health rather than a standalone trend. AI-enabled imaging review, laboratory result interpretation, clinical decision support, and tele-triage can help veterinarians prioritize cases, reduce administrative burden, and improve consistency in routine workflows.

The strongest near-term value lies in augmenting veterinary professionals, not replacing them. AI tools can support wearable-based monitoring, early disease detection, inventory forecasting, pharmacovigilance, and personalized care reminders. However, adoption depends on validated algorithms, transparent data governance, cybersecurity, clinician oversight, and compliance with veterinary medical standards.

Key Regional Insights

Asia-Pacific is gaining momentum as urbanization, rising disposable income, and pet humanization increase demand for vaccines, diagnostics, nutrition, and clinic services, with China, India, Japan, South Korea, and Australia serving as distinct growth engines. North America remains one of the most mature regions, supported by high pet ownership, advanced veterinary infrastructure, strong pet insurance adoption compared with many regions, and rapid uptake of specialty therapeutics.

Latin America is advancing through expanding private veterinary networks in Brazil and Mexico, while Europe benefits from established animal welfare standards, sophisticated regulation, and strong preventive care adoption. The Middle East, especially high-income Gulf markets, is seeing premiumization in companion animal services, including specialty clinics and imported therapeutics. Africa remains more access-driven, with opportunities tied to vaccination, parasite control, rabies prevention, affordable diagnostics, and broader veterinary service availability.

Key Group Insights

ASEAN markets show rising demand for companion animal vaccines, nutrition, diagnostics, and retail veterinary services, although regulatory fragmentation requires localized market-entry planning. The GCC is characterized by import-driven premium veterinary products, growing specialty clinics, and owners willing to pay for advanced care in urban centers.

The European Union offers harmonized regulatory pathways, high animal welfare expectations, and strong demand for proven safety and efficacy. BRICS countries provide scale through large pet populations and expanding middle-class ownership, but pricing, access, and veterinary infrastructure vary widely. G7 markets anchor innovation, clinical standards, specialty therapeutics, and digital veterinary adoption, while NATO countries add relevance through biosecurity, working-dog health, supply-chain resilience, and coordinated animal health preparedness.

Key Country Insights

The United States leads in companion animal spending, specialty veterinary care, diagnostics, and innovation commercialization, while Canada emphasizes preventive care, professional veterinary standards, and regulated product quality. Mexico and Brazil are important Latin American markets, supported by growing urban pet ownership, expanding clinic networks, vaccination demand, and increasing use of parasite prevention.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine high pet ownership with advanced veterinary services, strong retail channels, and preventive medicine adoption, while Russia remains a sizable but complex market influenced by access, regulation, and trade conditions. In Asia-Pacific, China and India offer scale through expanding pet populations and rising urban ownership, Japan and South Korea show strong premiumization and advanced clinic standards, and Australia is notable for high pet ownership, preventive care, biosecurity awareness, and mature clinical practices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize portfolios that align with verified clinical need: preventive care, dermatology, pain management, parasiticides, vaccines, diagnostics, dental health, nutrition, and chronic disease monitoring. Commercial teams should support veterinarians with evidence, education, pharmacovigilance, and workflow-friendly tools rather than relying only on consumer marketing.

Companies should validate AI and digital health tools in real-world veterinary settings, build compliant data systems, and localize pricing, packaging, and distribution by region. Partnerships with clinics, diagnostic laboratories, insurers, e-commerce platforms, shelters, and academic institutions can improve access while strengthening trust in companion animal health brands.

Research Methodology

This executive summary is based on triangulated secondary research from veterinary regulatory agencies, animal health associations, peer-reviewed literature, trade data, and recognized pet ownership sources, including APPA, FEDIAF, FDA CVM, EMA, WOAH, and national veterinary bodies.

Insights were developed by comparing demand indicators such as pet ownership, veterinary expenditure, clinic infrastructure, product approvals, disease-prevention priorities, insurance penetration, regulatory requirements, and digital adoption. Regional, group, and country assessments emphasize verified structural drivers rather than unsubstantiated forecasts, market sizing, or market share assumptions.

Conclusion

Companion animal health is positioned for durable expansion as pet humanization, preventive medicine, veterinary innovation, and digital care converge. The market is no longer defined only by pharmaceuticals or clinic visits; it now includes integrated diagnostics, nutrition, monitoring, telehealth support, insurance-enabled care, and data-enabled care pathways.

Organizations that combine scientific credibility, regulatory discipline, veterinarian-centered commercialization, and responsible AI adoption will be best positioned to capture long-term value. The strongest opportunities will come from improving access, outcomes, affordability, and trust across diverse global pet care markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Human-Animal Bond Sustains Essential-Care Spending
4.3.1.2. Chronic and Specialty Care Expand Lifetime Health Demand
4.3.1.3. Diagnostics and Data Enable Earlier Clinical Intervention
4.3.1.4. Emerging Disease and Vector Risk Reinforce Preventive Care
4.3.1.5. Insurance and Payment Innovation Improve Treatment Conversion
4.3.1.6. Asia-Pacific Modernization and Omnichannel Access Broaden Demand
4.3.2. Key Restraints
4.3.2.1. Household Affordability Limits Care Intensity
4.3.2.2. Veterinary Workforce and Workflow Capacity Restrict Throughput
4.3.2.3. Regulatory Fragmentation Slows Cross-Border Scale
4.3.2.4. Supply Concentration and Trade Volatility Increase Cost and Risk
4.3.2.5. Evidence, Trust, and Adherence Gaps Slow Novel Care
4.3.3. Key Opportunities
4.3.3.1. Build Feline-Specific Chronic and Preventive Care Pathways
4.3.3.2. Scale Molecular and AI-Enabled Point-of-Care Diagnostics
4.3.3.3. Commercialize Connected Chronic-Care Programs
4.3.3.4. Develop Long-Acting and Adherence-Oriented Therapeutics
4.3.3.5. Use MUMS Pathways to Address Underserved Species and Indications
4.3.3.6. Connect Veterinary Recommendation with Authorized Digital Fulfillment
4.3.4. Key Challenges
4.3.4.1. Validate AI and Integrate Fragmented Clinical Data
4.3.4.2. Balance Antimicrobial Stewardship with Timely Infection Management
4.3.4.3. Maintain Quality Across Globalized Manufacturing Networks
4.3.4.4. Convert Innovation into Affordable, Workflow-Compatible Care
4.3.4.5. Manage Disease, Climate, and Mobility Risks Across Borders
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Companion Animal Health Market, by Animal Type
7.1. Introduction
7.2. Dogs
7.3. Cats
7.4. Horses
7.5. Birds
7.6. Small Companion Mammals
7.7. Ornamental Fish
7.8. Reptiles & Amphibians
8. Companion Animal Health Market, by Offering Type
8.1. Introduction
8.2. Pharmaceuticals
8.2.1. Prescription Pharmaceuticals
8.2.2. Nonprescription Pharmaceuticals
8.3. Diagnostics
8.3.1. In Vitro Diagnostics
8.3.1.1. Clinical Chemistry & Hematology
8.3.1.2. Immunodiagnostics
8.3.1.3. Molecular Diagnostics
8.3.1.4. Microbiology & Parasitology
8.3.1.5. Pathology & Cytology
8.3.2. Diagnostic Imaging
8.3.3. In-Clinic Physiologic Monitoring
8.4. Vaccines
8.5. Nutritional Health Products
8.5.1. Therapeutic Diets
8.5.2. Supplements & Nutraceuticals
8.6. Therapeutic Devices & Clinical Consumables
8.6.1. Clinical Consumables
8.6.2. Surgical & Dental Equipment
8.6.3. Anesthesia Delivery & Life-Support Equipment
8.6.4. Rehabilitation & Mobility Devices
8.7. Digital Care Platforms
8.7.1. Practice Management & Clinical Decision Software
8.7.2. Telehealth Platforms
8.7.3. Remote Monitoring & Connected Care
9. Companion Animal Health Market, by Clinical Application
9.1. Introduction
9.2. Parasite Control
9.3. Dermatology
9.4. Gastrointestinal, Oral & Metabolic Care
9.5. Vaccination & Immunological Prevention
9.6. Musculoskeletal Care
9.7. Infectious Disease Management
9.8. Oncology & Immune-Mediated Disease
9.9. Neurology & Behavioral Care
9.10. Cardiovascular Care
9.11. Endocrine & Hormonal Care
9.12. Ophthalmic & Otic Care
9.13. Genitourinary & Reproductive Care
9.14. Emergency, Toxicology & Supportive Care
9.15. Hematology
9.16. Respiratory Care
10. Companion Animal Health Market, by Distribution Channel
10.1. Introduction
10.2. Veterinary Channel
10.3. Brick-and-Mortar Retail
10.4. E-commerce
11. Companion Animal Health Market, by Care Setting
11.1. Introduction
11.2. Facility-Based Veterinary Care
11.3. Owner-Administered Home Care
11.4. Reference Diagnostic Laboratories
11.5. Breeding, Boarding & Training Facilities
11.6. Mobile & Ambulatory Veterinary Care
11.7. Research & Teaching Facilities
11.8. Shelters & Population Health Facilities
12. Companion Animal Health Market, by Region
12.1. North America
12.2. Europe
12.3. Asia-Pacific
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Companion Animal Health Market, by Group
13.1. NATO
13.2. G7
13.3. European Union
13.4. BRICS
13.5. ASEAN
13.6. GCC
14. Companion Animal Health Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. Japan
14.5. United Kingdom
14.6. France
14.7. Brazil
14.8. Canada
14.9. Italy
14.10. Australia
14.11. Spain
14.12. India
14.13. South Korea
14.14. Russia
14.15. Mexico
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Zoetis Inc.
16.2. IDEXX Laboratories, Inc.
16.3. Boehringer Ingelheim International GmbH
16.4. Merck & Co., Inc.
16.5. Elanco Animal Health Incorporated
16.6. Mars, Incorporated
16.7. Virbac S.A.
16.8. Colgate-Palmolive Company
16.9. Nestlé S.A.
16.10. Vetoquinol S.A.
16.11. Alltech, Inc.
16.12. Phibro Animal Health Corporation
16.13. Aurora Pharmaceutical, Inc.
16.14. Neogen Corporation
16.15. Ceva Santé Animale SA
16.16. Covetrus, Inc.
16.17. Cronus Pharma
16.18. Dechra Pharmaceuticals PLC
16.19. Diamond Animal Health
16.20. ZenexAnimal Health India Private Limited
16.21. Dorwest Herbs Ltd.
16.22. Dômes Pharma Group
16.23. Kemin Industries, Inc.
List of Figures
FIGURE 1. GLOBAL COMPANION ANIMAL HEALTH MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL COMPANION ANIMAL HEALTH MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL COMPANION ANIMAL HEALTH MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL COMPANION ANIMAL HEALTH MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2025 VS 2032 (%)
FIGURE 15. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL COMPANION ANIMAL HEALTH MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL COMPANION ANIMAL HEALTH MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL COMPANION ANIMAL HEALTH MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BIRDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SMALL COMPANION MAMMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SMALL COMPANION MAMMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SMALL COMPANION MAMMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ORNAMENTAL FISH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ORNAMENTAL FISH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ORNAMENTAL FISH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL REPTILES & AMPHIBIANS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL REPTILES & AMPHIBIANS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL REPTILES & AMPHIBIANS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PRESCRIPTION PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PRESCRIPTION PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PRESCRIPTION PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL NONPRESCRIPTION PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL NONPRESCRIPTION PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL NONPRESCRIPTION PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CLINICAL CHEMISTRY & HEMATOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CLINICAL CHEMISTRY & HEMATOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICAL CHEMISTRY & HEMATOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MICROBIOLOGY & PARASITOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MICROBIOLOGY & PARASITOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MICROBIOLOGY & PARASITOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL PATHOLOGY & CYTOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL PATHOLOGY & CYTOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL PATHOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL IN-CLINIC PHYSIOLOGIC MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL IN-CLINIC PHYSIOLOGIC MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL IN-CLINIC PHYSIOLOGIC MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL NUTRITIONAL HEALTH PRODUCTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL NUTRITIONAL HEALTH PRODUCTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL NUTRITIONAL HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL THERAPEUTIC DIETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL THERAPEUTIC DIETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL THERAPEUTIC DIETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SUPPLEMENTS & NUTRACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SUPPLEMENTS & NUTRACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SUPPLEMENTS & NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL THERAPEUTIC DEVICES & CLINICAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL THERAPEUTIC DEVICES & CLINICAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL THERAPEUTIC DEVICES & CLINICAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CLINICAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CLINICAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CLINICAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SURGICAL & DENTAL EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SURGICAL & DENTAL EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SURGICAL & DENTAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ANESTHESIA DELIVERY & LIFE-SUPPORT EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ANESTHESIA DELIVERY & LIFE-SUPPORT EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ANESTHESIA DELIVERY & LIFE-SUPPORT EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL REHABILITATION & MOBILITY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL REHABILITATION & MOBILITY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL REHABILITATION & MOBILITY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DIGITAL CARE PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DIGITAL CARE PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL DIGITAL CARE PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL PRACTICE MANAGEMENT & CLINICAL DECISION SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL PRACTICE MANAGEMENT & CLINICAL DECISION SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PRACTICE MANAGEMENT & CLINICAL DECISION SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL TELEHEALTH PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL TELEHEALTH PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL TELEHEALTH PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL REMOTE MONITORING & CONNECTED CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL REMOTE MONITORING & CONNECTED CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL REMOTE MONITORING & CONNECTED CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PARASITE CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL PARASITE CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL PARASITE CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL DERMATOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL GASTROINTESTINAL, ORAL & METABOLIC CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL GASTROINTESTINAL, ORAL & METABOLIC CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL GASTROINTESTINAL, ORAL & METABOLIC CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL VACCINATION & IMMUNOLOGICAL PREVENTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL VACCINATION & IMMUNOLOGICAL PREVENTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL VACCINATION & IMMUNOLOGICAL PREVENTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL MUSCULOSKELETAL CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL MUSCULOSKELETAL CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL MUSCULOSKELETAL CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL INFECTIOUS DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL INFECTIOUS DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL INFECTIOUS DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ONCOLOGY & IMMUNE-MEDIATED DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ONCOLOGY & IMMUNE-MEDIATED DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ONCOLOGY & IMMUNE-MEDIATED DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL NEUROLOGY & BEHAVIORAL CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL NEUROLOGY & BEHAVIORAL CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL NEUROLOGY & BEHAVIORAL CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL CARDIOVASCULAR CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL CARDIOVASCULAR CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL CARDIOVASCULAR CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL ENDOCRINE & HORMONAL CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL ENDOCRINE & HORMONAL CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL ENDOCRINE & HORMONAL CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL OPHTHALMIC & OTIC CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL OPHTHALMIC & OTIC CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL OPHTHALMIC & OTIC CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL GENITOURINARY & REPRODUCTIVE CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL GENITOURINARY & REPRODUCTIVE CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL GENITOURINARY & REPRODUCTIVE CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL EMERGENCY, TOXICOLOGY & SUPPORTIVE CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL EMERGENCY, TOXICOLOGY & SUPPORTIVE CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL EMERGENCY, TOXICOLOGY & SUPPORTIVE CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL HEMATOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL HEMATOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL RESPIRATORY CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL RESPIRATORY CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL RESPIRATORY CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL VETERINARY CHANNEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL VETERINARY CHANNEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL VETERINARY CHANNEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL BRICK-AND-MORTAR RETAIL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL BRICK-AND-MORTAR RETAIL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL BRICK-AND-MORTAR RETAIL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL E-COMMERCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL E-COMMERCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL E-COMMERCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL FACILITY-BASED VETERINARY CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL FACILITY-BASED VETERINARY CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL FACILITY-BASED VETERINARY CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL OWNER-ADMINISTERED HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL OWNER-ADMINISTERED HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL OWNER-ADMINISTERED HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL REFERENCE DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL REFERENCE DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL REFERENCE DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL BREEDING, BOARDING & TRAINING FACILITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL BREEDING, BOARDING & TRAINING FACILITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL BREEDING, BOARDING & TRAINING FACILITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL MOBILE & AMBULATORY VETERINARY CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL MOBILE & AMBULATORY VETERINARY CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL MOBILE & AMBULATORY VETERINARY CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL RESEARCH & TEACHING FACILITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL RESEARCH & TEACHING FACILITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL RESEARCH & TEACHING FACILITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL SHELTERS & POPULATION HEALTH FACILITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL SHELTERS & POPULATION HEALTH FACILITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL SHELTERS & POPULATION HEALTH FACILITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 185. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 186. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 187. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 188. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 189. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 190. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 192. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 193. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 194. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 195. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 196. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 197. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 198. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 199. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 200. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 201. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 202. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 203. EUROPE COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 216. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 218. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 219. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 220. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 221. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 222. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 223. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 224. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 225. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 227. LATIN AMERICA COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 228. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 229. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 230. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 231. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 232. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 233. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 234. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 235. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 236. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 237. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 238. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 239. AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 240. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 241. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 242. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 243. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 244. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 245. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 246. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 247. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 248. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 249. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 251. MIDDLE EAST COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 252. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 253. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 254. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 255. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 256. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 257. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 258. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 259. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 260. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 261. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 262. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 263. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 264. NATO COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 265. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 266. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 267. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 268. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 269. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 270. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 271. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 272. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 273. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 274. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 275. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 276. G7 COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 289. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 290. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 291. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 292. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 293. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 294. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 295. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 296. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 297. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 298. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 299. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 300. BRICS COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 301. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 302. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 303. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 304. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 305. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 306. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 307. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 308. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 309. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 310. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 311. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 312. ASEAN COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 313. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 314. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 315. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 316. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 317. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 318. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 319. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 320. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 321. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 322. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 323. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 324. GCC COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 325. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 326. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 328. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY OFFERING TYPE, 2017-2032 (USD MILLION)
TABLE 329. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 330. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 331. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY IN VITRO DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 332. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL HEALTH PRODUCTS, 2017-2032 (USD MILLION)
TABLE 333. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC DEVICES & CLINICAL CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 334. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY DIGITAL CARE PLATFORMS, 2017-2032 (USD MILLION)
TABLE 335. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 336. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 337. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 338. CHINA COMPANION ANIMAL HEALTH MARKET SIZE, 2017-2032 (US

Companies Mentioned

  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Mars, Incorporated
  • Virbac S.A.
  • Colgate-Palmolive Company
  • Nestlé S.A.
  • Vetoquinol S.A.
  • Alltech, Inc.
  • Phibro Animal Health Corporation
  • Aurora Pharmaceutical, Inc.
  • Neogen Corporation
  • Ceva Santé Animale SA
  • Covetrus, Inc.
  • Cronus Pharma
  • Dechra Pharmaceuticals PLC
  • Diamond Animal Health
  • ZenexAnimal Health India Private Limited
  • Dorwest Herbs Ltd.
  • Dômes Pharma Group
  • Kemin Industries, Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 26.46 Billion
Forecasted Market Value ( USD ) by 2032 $ 43.44 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Animal Health Market - Global Forecast 2026-2032 - Product Image

Animal Health Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Animal Health Monitoring Software Market - Global Forecast 2026-2032 - Product Image

Animal Health Monitoring Software Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Companion Animal Health - Global Strategic Business Report - Product Image

Companion Animal Health - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
AI in Animal Health - Global Strategic Business Report - Product Image

AI in Animal Health - Global Strategic Business Report

  • Report
  • 180 Pages
  • Global
From
Companion Animal Health Market Size, Share, Trends and Forecast by Animal Type, Product, End User, and Region, 2026-2034 - Product Image

Companion Animal Health Market Size, Share, Trends and Forecast by Animal Type, Product, End User, and Region, 2026-2034

  • Report
  • 150 Pages
  • Global
From

About the Pet Health Market

The Pet Health market is a segment of the Animal Healthcare/Veterinary industry that focuses on the health and wellbeing of companion animals. This includes preventive care, such as vaccinations and parasite control, as well as diagnostics, treatments, and surgeries. Pet Health also encompasses nutrition, behavior, and lifestyle advice for pet owners. The Pet Health market is driven by the increasing humanization of pets, with pet owners increasingly viewing their animals as family members. This has led to a rise in demand for pet health services, such as preventive care, diagnostics, and treatments. Additionally, the growing availability of pet health products, such as pet food and supplements, has further contributed to the growth of the Pet Health market. Notable companies in the Pet Health market include Banfield Pet Hospital, Petco, PetSmart, VCA Animal Hospitals, and National Veterinary Associates. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.